---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-25-000088"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:08:00.320579+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# GoodRx stockholders elect three Class II directors and ratify auditor at 2025 annual meeting

## Summary
- Elected Christopher Adams, Trevor Bezdek, and Scott Wagner as Class II directors; each received >2.6B votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY 2025; 99.9% voted for (2.66B for).
- Advisory say-on-pay approved with 2.62B votes for (99.9% of votes cast excluding abstentions).
- Total voting power at meeting represented ~99.5% of outstanding shares; Class B shares hold 10 votes each.

## SEC filing metadata
- accession: 0001809519-25-000088
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000088/0001809519-25-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000088/gdrx-20250603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-25-000088
- JSON: https://secwatch.observer/filing/0001809519-25-000088.json
- Plain text: https://secwatch.observer/filing/0001809519-25-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.